Results 51 to 60 of about 365,101 (202)

Reasons for switching immunosuppression and adverse events.

open access: yes, 2014
CNI, calcineurin inhibitor; IS, immunosuppression; P-values are from the Fisher's Exact test; due to small frequencies some P-values are not reported.Reasons for switching immunosuppression and adverse events.
Stefan Reuter (199795)   +10 more
core   +1 more source

Considering local immunity for innovative immunomodulatory approaches: pulmonary sepsis as a use case

open access: yesFrontiers in Immunology
Owing to faster identification of sepsis and improvement of patient management, most septic patients now survive the early phase of sepsis. Therefore, one of the major challenges in sepsis management today is to identify those patients at risk and ...
Emilie Vernay   +14 more
doaj   +1 more source

Whole blood ratio of CDK1/CX3CR1 mRNA expression combined to lactate refines the prediction of ICU mortality in septic patients in the Sepsis-3 era: a proof-of-concept study

open access: yesFrontiers in Medicine
BackgroundTranscriptomics biomarkers have been widely used to predict mortality in patients with sepsis. However, the association between mRNA levels and outcomes shows substantial variability over the course of sepsis, limiting their predictive ...
Marie-Angélique Cazalis   +12 more
doaj   +1 more source

Immunostimulatory effect of beta-glucan at drug-induced immunosuppression in guinea pigs

open access: yes, 2020
The peculiarity of beta-glucan action is the effect on all leukocyte populations, which is accompanied by the activation of phagocytic function. Corticosteroid hormones have an immunosuppressive effect.
Yu. V. Martyniv, Ya. V. Kisera
core   +1 more source

Polymicrobial sepsis and non-specific immunization induce adaptive immunosuppression to a similar degree. [PDF]

open access: yesPLoS ONE, 2018
Sepsis is frequently complicated by a state of profound immunosuppression, in its extreme form known as immunoparalysis. We have studied the role of the adaptive immune system in the murine acute peritonitis model. To read out adaptive immunosuppression,
Katrin Schmoeckel   +4 more
doaj   +1 more source

Characteristics and immunosuppression therapy for SOT recipients.

open access: yes, 2022
Characteristics and immunosuppression therapy for SOT recipients.
Richard J. Knight (14279145)   +14 more
core   +1 more source

Supplementary Figure from Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma

open access: yes, 2022
Supplementary Figure from Circadian Regulator CLOCK Drives Immunosuppression in ...
Lizhi Pang (6372212)   +9 more
core   +2 more sources

Transplant Coordinators' Perceived Impact of Availability of Multiple Generic Immunosuppression Therapies on Patients, Workload, and Posttransplant Maintenance Therapy

open access: yesJournal of Transplantation, 2013
Background. No studies have evaluated the impact of multiple generic immunosuppression medications on transplant coordinators (TCs) and patients. Methods.
K. Parker   +3 more
doaj   +1 more source

Automated bedside flow cytometer for mHLA-DR expression measurement: a comparison study with reference protocol

open access: yesIntensive Care Medicine Experimental, 2017
Background In various ICU conditions, measurement of diminished expression of human leukocyte antigen-DR on circulating monocytes (mHLA-DR) by flow cytometry appears to be a reliable marker of acquired immunosuppression. Low mHLA-DR is associated with an
Mehdi Zouiouich   +4 more
doaj   +1 more source

Neuropathology of Immunosuppression

open access: yesBrain Pathology, 1992
Traditionally, the brain has been considered an “immunologically privileged” organ. Under normal conditions, the blood‐brain barrier (BBB) is highly effective in preventing both cellular and humoral constituents of the blood from entering the brain parenchyma. In certain pathological conditions, such as viral infections and demyelinating disorders, the
T W, Smith, U, De Girolami, W F, Hickey
openaire   +2 more sources

Home - About - Disclaimer - Privacy